A Growing Research Consortium

Posted October 3, 2016

As we expand our research efforts, we continue to seek out leading researchers who can speed progress toward a cure. We recently asked three highly respected researchers, all of whom bring different strengths to our team, to join our Research Consortium.

Ben Barres, M.D., Ph.D.
Stanford University, California

Originally from New Jersey, Dr. Barres is chair of neurobiology at Stanford University, with a research focus on microglial cells, the main component of the brain’s innate immune system. He earned a B.S. at M.I.T., an M.D. from Dartmouth College, a Ph.D. from Harvard Medical School, and did his postdoc training at University College London.

Bart De Strooper, M.D., Ph.D.
Vlaams Instituut voor
Biotechnologie (VIB), Belgium

A native of Belgium, Dr. De Strooper heads up the VIB Department of Molecular and Developmental Genetics at the Katholieke Universiteit Leuven (KU Leuven). As a molecular biologist and professor, he specializes in secretases, important drug targets that separate the amyloid peptide from the amyloid precursor protein (APP), the primary cause of plaques in the brain. He obtained an M.D. and a Ph.D. from KU and completed his postdoc work at the EMBL in Heidelberg, Germany. Together with fellow Research Consortium member Dr. Christian Haass, he received the Potamkin Prize in 2002.

Nancy Yuk-Yu Ip, Ph.D.
Hong Kong University of Science
and Technology, Hong Kong

Dr. Ip is our first researcher from Asia, demonstrating the impact of Alzheimer’s disease around the world. Her major research focus is on neurotrophic factors and the identification of novel molecular targets involved in the pathophysiology of neurodegenerative diseases.

We are very pleased to announce the addition of Drs. Barres, De Strooper, and Ip to our team of renowned global researchers.